Risperdal

(risperidone)
Company
Janssen
FDA Label

Indications

  • (12/29/1993)
    treatment of Schizophrenia
  • (06/10/1996)

    treatment of psychotic manifestations of mental disorders (solution)

  • (12/04/2003)
    short-term treatment of acute manic or mixed episodes associated with Bipolar I Disorder (as monotherapy or short-term combination therapy with lithium or valproate)
  • (10/06/2006)
    treatment of irritability associated with Autistic Disorder in children and adolescents, including symptoms of aggression towards others, deliberate self-injuriousness, temper tantrums, and quickly changing moods.
  • (08/22/2007)
    treatment of schizophrenia in adults and adolescents aged 13-17 years
  • (08/22/2007)
    short-term treatment of acute manic or mixed episodes associated with Bipolar I Disorder, alone or in combination with lithium or valproate in adults, and alone in children and adolescents aged 10-17 years
  • (08/22/2007)
    treatment of irritability associated with autistic disorder in children and adolescents aged 5-16 years

Movies